Your Gateway to Student Success
Kyowa Kirin is a fast‑growing global specialty pharmaceutical company that applies state‑of‑the‑art biotechnologies to discover and deliver novel medicines in four disease areas: bone and mineral; intractable hematologic; hematology oncology; and rare disease. A Japan‑based company, our goal is to translate science into smiles by delivering therapies where no adequate treatments currently exist, working from drug discovery to product development and commercialization. In North America, we are headquartered in Princeton, NJ, with offices in California, North Carolina, and Mississauga, Ontario.
Let’s work together to make people smile in this vital role to shape the U.S. launch of Rocatinlimab, an anti‑OX40 human monoclonal antibody being investigated in partnership with Amgen for the treatment of atopic dermatitis, asthma, prurigo nodularis, and other inflammatory diseases.
The National Sales Di...